TEL
+ 86-21-6420 0566
CAS NO.864070-44-0
| Объект | Подробнее |
| Химическое название | Эплеренон |
| Номер по CAS | 107724-20-9 |
| Молекулярная формула | \(C_{24}H_{30}O_6\) |
| Молекулярная масса | 414.49 |
| Молекулярная структура | Eplerenone has a steroid – like structure. It consists of a cyclopentanoperhydrophenanthrene ring system with various functional groups attached. There are carbonyl groups and a specific side – chain configuration that is crucial for its interaction with the mineralocorticoid receptor. |
| Внешний вид | Appears as a white to off – white crystalline powder. |
| Растворимость | Practically insoluble in water. It has better solubility in organic solvents such as chloroform, methanol, and ethanol. This solubility characteristic influences the formulation of eplerenone into pharmaceutical products, often requiring the use of solubilizing agents or specific formulation techniques. |
| Фармакологический класс | Антагонист альдостерона |
| Механизм действия | Eplerenone binds selectively to the mineralocorticoid receptor in the cytoplasm of target cells, mainly in the distal convoluted tubules of the kidneys. By blocking the binding of aldosterone to this receptor, it inhibits the aldosterone – induced sodium reabsorption and potassium excretion in the kidneys. This leads to increased sodium and water excretion (natriuresis and diuresis), which helps in reducing blood volume and blood pressure. In the context of heart failure, it also has beneficial effects on cardiac remodeling and reduces the risk of adverse cardiac events. |
| Медицинские применения | повышенное кровяное давление: Approved for the treatment of hypertension. It can be used alone or in combination with other antihypertensive drugs such as thiazide diuretics, calcium channel blockers, or angiotensin – converting enzyme (ACE) inhibitors. Остановка сердца: Eplerenone is also indicated for the treatment of patients with left ventricular systolic dysfunction after myocardial infarction. It helps in reducing morbidity and mortality associated with heart failure by improving cardiac function and reducing the harmful effects of aldosterone – mediated cardiac remodeling. |
| Стабильность | Stable under normal storage conditions, typically at room temperature in a dry place protected from light. However, exposure to high humidity, extreme temperatures, or strong oxidizing or reducing agents may cause degradation of the drug, potentially affecting its potency and safety. |
| Вопросы безопасности | Common side effects include hyperkalemia (elevated potassium levels in the blood), which can be a serious concern, especially in patients with impaired renal function or those taking other medications that can increase potassium levels, such as potassium – sparing diuretics or ACE inhibitors. Other side effects may include dizziness, fatigue, diarrhea, and hypotension. Eplerenone may also interact with other drugs. For example, drugs that inhibit CYP3A4 (the enzyme responsible for metabolizing eplerenone) can increase its blood levels and the risk of adverse effects. |
Эмпаглифлозин (BI 10773) является эффективным селективным ингибитором SGLT-2 с IC50 3.1 нМ, что более чем в 300 раз выше, чем у SGLT-1, 4, 5 и 6. Фаза 3.
Отказ от ответственности: приведенный выше контент предназначен только для справки и общения среди инсайдеров отрасли и не гарантирует его точность или полноту. Согласно соответствующим законам и правилам, а также правилам этого веб-сайта, подразделения или лица, которые покупают соответствующие товары, должны получить действительные квалификации и условия квалификации.
Фабрика и отгрузка
